title: Equilibrium and release properties of hyaluronic acid-drug complexes.
abstract: With the aim to provide more rational basis about the potentiality of hyaluronic acid (or hyaluronan) as drug carrier a set of ionic complexes of its acid form (HA) and its sodium salt (NaHA) with three model drugs (D) (atenolol, propranolol and lidocaine) were prepared. Besides NaHA subjected to hyalurodinase depolimerization (NaHA(d)) was also used. Transparent dispersions were obtained. They exhibited negative electrokinetic potential and a high degree of counterionic condensation with affinity constants (log Kcc) in the range of 5.8-6.1 for propranolol complexes (pK(a) 9.45) and 4.0-4.6 for lidocaine ones (pK(a) 7.92). Delivery rates of D from the complexes were measured in a Franz-type bicompartimental device. Loaded D were slowly released from the three types of complexes, even when a neutral salt was added to the dispersion placed in the donor compartment, revealing the high affinity between the protonated drugs and the ionisable groups of the polymer. Complex dispersions based on HA or on NaHA(d) exhibited lower viscosity than those of NaHA but their complexing ability remained unaltered. The results reported on equilibrium and release properties of Hyaluronan-model D complexes contribute to expand the use of HA and NaHA as drug carriers for different routes of administration.
authors: Departamento de Farmacia, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Ciudad Universitaria, X5000HUA Córdoba, Argentina.
authors: Franco David
authors: FD
authors: Battistini
authors: María Eugenia
authors: ME
authors: Olivera
authors: Rubén Hilario
authors: RH
authors: Manzo
mesh_terms: D001262:Atenolol / Q000737:chemistry; D004337:Drug Carriers / Q000737:chemistry*; D006820:Hyaluronic Acid / Q000737:chemistry*; D008012:Lidocaine / Q000737:chemistry; D011433:Propranolol / Q000737:chemistry; D014783:Viscosity
chemical_list: D004337:Drug Carriers; D001262:Atenolol; D006820:Hyaluronic Acid; D008012:Lidocaine; D011433:Propranolol
keywords: Biopolymer; Controlled release; Drug; Hyaluronidase; Polyelectrolyte complexes